Candid-Y

NDC

55714-2567

Route

Oral

Therapeutic class

Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine , Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract , Non-Standardized Food Allergenic Extract , Non-Standardized Fungal Allergenic Extract , Non-Standardized Fungal Allergenic Extract , Non-Standardized Fungal Allergenic Extract , Non-Standardized Fungal Allergenic Extract , Nut Proteins [EXT], alpha-Adrenergic Agonist , beta-Adrenergic Agonist

Marketing category

UNAPPROVED HOMEOPATHIC